Posology : מינונים

4.2    Posology and method of administration

Posology
The recommended dose is one inhalation of 322 micrograms aclidinium twice daily.
If a dose is missed the next dose should be taken as soon as possible. However, if it is nearly time for the next dose, the missed dose should be skipped.

Elderly
No dose adjustments are required for elderly patients (see section 5.2).

Renal impairment
No dose adjustments are required for patients with renal impairment (see section 5.2).
Hepatic impairment
No dose adjustments are required for patients with hepatic impairment (see section 5.2).

Paediatric population
There is no relevant use of Eklira Genuair in children and adolescents (under 18 years of age) for the indication of COPD.


1
EU PI 06 2018
Method of administration
For inhalation use.
Patients should be instructed on how to administer the product correctly as the Genuair inhaler may work differently from inhalers the patients may have used previously. It is important to instruct the patients to carefully read the instructions for use in the Package Leaflet, which is packed together with each inhaler.


For instructions for use, see section 6.6.